The effects of hyperdynamic therapy on patients with cerebral vasospasm following subarachnoid hemorrhage (SAH), under normal blood pressure (BP) and normal blood volume conditions, are reported. Forty-four patients, who underwent surgery for aneurysms in acute stage, received hydroxy ethyl starch (500 ml/day) postoperatively to prevent dehydration. Twenty-four of the 44 patients with prominent SAH on the computed tomographic (CT) scan, anticipating to develop cerebral ischemia due to vasospasm, were given dobutamine (DOB). The BP was maintained within the normal range, and the heart rate was kept below 130/min. In the 24 patients treated with DOB, cerebral blood flow (CBF) was measured repeatedly by the 133Xe intravenous injection method. In 8 of these 24 patients, the cardiovascular function was monitored with Swan-Ganz (S-G) catheters. Twelve of the 44 patients (27%) developed delayed neurological deficits associated with cerebral vasospasm. The neurological deficits were reversed by the administration of DOB, at a dose of 8-25 (average 12.4),ug/ kg/min. In 43 patients, the ischemic lesions associated with vasospasm did not appear on CT scan and the patients were of normal condition at discharge. However, one patient showed multiple low-density lesions on CT scan. This was because of the failure of hyperdynamic therapy due to pulmonary com plications. No case of pulmonary edema or heart failure due to volume overload was noted. In the 24 patients with prominent SAH, CBF increased significantly by up to 20% following DOB adminis tration, although the BP stayed in the normal range. In the 8 patients monitored with S-G catheter, the cardiac index increased markedly after treatment with DOB, but the pulmonary wedge pressure was remained below 10 mmHg. There were no significant changes in either the stroke volume index (SI) or the stroke-CBF (CBF/heart rate). Hyperdynamic therapy with DOB is effective for the postoperative management of cerebral vasospasm, and neither induced hypertension nor hypervolemia was necessary. DOB had positive inotropic effects, but did not decrease the SI or stroke-CBF, so that hyperdynamic therapy with DOB increased the CBF in patients with vasospasm, and caused no side effects.
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Introduction
Cerebral vasospasm following subarachnoid hemor rhage (SAH) is well known and has been discussed considerably. However, no safe and reliable therapy has yet been developed, and the disorder still remains a serious problem greatly affecting the prognosis for the patient. Many reports have suggested that the so-called hypervolemic-hypertensive therapy is effective for preventing and treating cerebral vaso spasm,'v13"5 but such therapy often causes complica tions such as heart failure, pulmonary edema, and cerebral edema because it is a non-homeostatic thera py, and physicians often experience considerable difficulties in managing patients with the therapy.',") We believe that this therapy acts essentially by im proving cerebral circulation associated with damaged autoregulation by increasing the cardiac output and thereby maintaining systemic circulation at a hyper dynamic condition characterized by an accelerated cardiac function.
In this study we succeeded in preventing any complications while achieving good therapeutic results in patients with cerebral vaso spasm by hyperdynamic systemic circulation man agement while maintaining blood pressure (BP) and systemic blood volume within the normal range.
Materials and Methods
The study involved 44 patients who were admitted to our institute from January 1987 through September 1988, and underwent surgery for aneurysms within 3 days after the onset of SAH. There were 15 male and 29 female patients with ages ranging from 34 to 77 years (mean, 55 years). Table 1 shows the locations of aneurysms, neuro logical condition on admission according to Hunt & Kosnik's classification,') and the computed tomo graphic (CT) grade of SAH according to Fisher's classification.5) Postoperatively, patients received the usual fluid transfusions and meals together with 500 ml of hydroxyethyl starch (Hespander R) every day to prevent dehydration.
If ischemic symptoms due to cerebral vasospasm occurred, the patient received dobutamine (DOB) at an initial dosage of 3,ug/kg/min, which was gradually increased until the symptoms disappeared.
In addition, if the devel opment of cerebral vasospasm was predictable from severe SAH on admission, the patient similarly received DOB. Hypertensive patients began to re ceive various antihypertensive agents from the first day of admission so that their systolic BP could be controlled below 160 mmHg.
The cerebral blood flow (CBF) in the patients with DOB administration was measured repeatedly by the 10 mCi 133Xe intravenous injection method in order to calculate the whole-brain average of the initial slope index (ISI). In 8 of such patients, Swan-Ganz (S-G) catheters were emplaced in order to calculate the cardiac index (CI), systemic vascular resistance in dex (SVRI), stroke volume index (SI), and pulmonary wedge pressure (PWP) in an attempt to determine the changes in the cardiovascular function before and after the DOB administration.
Furthermore, the changes in the CBF value divided by the heart rate were also investigated in terms of the stroke-CBF, which is the CBF for every pulse beat.
The paired Student t-test was employed for statistical analysis, in which the level of 5% or less was accepted as a significant difference. 12.4) . In 43 patients (98%), no ischemic lesions associated with vasospasm appeared on CT scans and the patients were in normal condi tion at discharge (Table 2 ). However, the CT scan of one patient with severe bronchopneumonia show ed multiple low-density lesions (Fig. 1) . No compli cations such as pulmonary edema, heart failure, hemorrhagic infarction, and brain swelling occurred, although mild electrolyte imbalances were observed in 5 patients. Polyuria and tachycardia were also absent. Table 2 Outcome of 44 patients *The patient had severe bronchopneumonia (cf . Fig.   1 ).
11. Effect of DOB on cerebral circulation and systemic circulation Measurements of CBF were made before and after the DOB administration in 24 patients, in all of whom the CBF showed a significant increase by more than 20% from a mean of 40.2 to a mean of 48.8 ml/100 gm/min. However, no change was ob served in the stroke-CBF (Fig. 2) . The DOB adminis tration was followed by significant increases in the heart rate, systolic BP, and pulse pressure whereas the mean BP and diastolic BP remained unchanged (Fig. 3) . There was no patient in whom BP and heart rate had to be maintained at a high level in order to improve the ischemic symptoms due to vasospasm.
For the 8 patients in whom the cardiovascular func tion was monitored with S-G catheter, CI showed a significant increase from 3.4 to 4.91/min/m2. SVRI significantly decreased from 2465 to 1852 dyne .sec . cm-5 .m2 whereas SI was unchanged and PWP was kept below 10 mmHg in all 8 patients (Fig. 4) . Fig. 2 Changes in CBF (n = 24) and stroke-CBF (n = 8 , CBF divided by heart rate, meaning CBF for every pulse beat). CBF increased significant ly up to 20% after treatment with dobutamine (DOB), although there were no significant elevations in stroke-CBF. *p < 0.001. Fig. 3 Changes in BP, pulse pressure, and heart rate (n = 24). Systolic BP, pulse pressure, and heart rate increased significantly after DOB treat ment. There was no significant change in mean or diastolic BP. *p < 0.05, **p < 0.01.
Discussion
The therapeutic approaches to cerebral vasospasm may be divided into two major categories; one is treatment from the outside of blood vessels and the other is treatment from the inside of blood vessels. Treatment from the outside of blood vessels may be represented by the removal of subarachnoid hematoma in aneurysm surgery. The procedure aims at preventing cerebral vasospasm by removing sub arachnoid hematoma16) but, according to our experi ence, they are more liable to cause excessive brain retraction and damage to the perforating arteries because they require an adequately large operating field.") Furthermore, if the patient requires a bi lateral craniotomy, the procedure is associated with severe operative invasion, making it difficult for a I. Limitations of hypervolemic-hypertensive thera py Hypervolemic therapy aims at improving cerebral circulation by increasing the systemic blood volume and raising the left ventricular diastolic pressure, thus increasing cardiac output. However, if a hyper volemic condition is to be maintained in a patient having a normal renal function, a large fluid trans fusion volume exceeding the urine volume must be given. Such a fluid transfusion often causes compli cations including pulmonary edema, heart failure, bleeding tendency, and electrolyte imbalances, and hence the patient must be subject to strict monitor ing using S-G catheter and other methods.") In ad dition, the use of a plasma expander such as albumin has a social limitation because of the high cost and thus cannot be administered in safety and in large doses as a volume expander. Finn et al.') found that the changes in PWP well correlated with alleviation in the aggravation of neurological symptoms, but that its critical level was hazardous since it was close to the critical level of heart failure, suggesting limi tations for the non-homeostatic management of pa tients. The problem is that it is an attempt to main tain systemic circulation in a hyperdynamic condition by hypervolemia only. In short, the therapy cannot be recommended for elderly patients and patients with cardiovascular disorders. Hypertensive therapy aims at improving the cerebral circulation by increasing the systemic BP and hence increasing the cerebral perfusion pressure. However, an excessive increase in the BP may pro mote cerebral edema and hemorrhagic infarction." Furthermore, administration of catecholamine in large doses may cause marked tachycardia and ar rhythmia. The therapy has thus many problems in the actual management of patients. An attempt to raise the BP by angiotensin may lead to an increase in the peripheral vascular resistance, resulting in an increase in afterload, as a result of which the cardiac output decreases instead of increases,") thereby causing hypodynamic conditions. So even if the peripheral vascular resistance other than the cerebral circulation increases, resulting in an increase in the percentage of cerebral circulation blood volume of the total stroke volume, the CBF may eventually decrease, provided that a decrease in the whole car diac output occurs (Fig. 5) . Our experience includes a case with hypertension in which we did not provide countermeasures against cerebral vasospasm because the BP was too high and the patient eventually incurred symptomatic vasospasm, which resulted in serious neurological deficits. The limitations to this therapy seen to be because attention is directed to the perfusion-pressure difference of the cerebral circula tion alone on the basis of the assumption tha cerebral circulation is just like water flowing throug: a pipe.
Both hypervolemic therapy and hypertensiv therapy are based on the administration of, for exam ple, dopamine, and may be classified as methods aim ing at the hyperdynamic control of patients by in creasing cardiac output if considered from the aspec of systemic circulation. Tanabe et a1.15) and Finn E al.') also pointed out the importance of hyper dynamic control of the systemic circulation, bu there is a limit to the increase in cardiac output b volume overload, and if further hyperdynami control is required, catecholamine must be admini, tered. If used independently, both hypervolemi therapy and hypertensive therapy are inadequate t improve the cerebral circulation, and patient con trol with them is considered to be very complicate and uncontrollable.
Conversely, if the cardia function has been accelerated sufficiently enough t improve the cerebral circulation in the period c cerebral vasospasm, there is no necessity for th control to promote further over-hydration and significant increase of BP. The therapy reporte here has improved this aspect, and it can be said the DOB administration while preventing dehydratio provided safe patient control and a reliable metho to improve cerebral circulation. BP increased, although CO, SV, and stroke-CBF decreased.
II. Hyperdynamic therapy
No clear explanation of why the cerebral circula tion in the period of cerebral vasospasm can be im proved by hyperdynamic control of systemic circula tion in the literature. In experiments using normal adult cats, Davis and Sundt2) found that CBF was decreased by hypovolemia induced by phlebotomy. Their findings are based on physiological control of cerebral circulation but may also be applicable to cerebral circulation in cerebral vasospasm, by sug gesting that hypovolemia caused by dehydration may decrease vascular beds and lower CBF. They also reported that even when a hyperdynamic state was produced by an increase in the cardiac output by administration of isoproterenol, the CBF remained unchanged. This statement should be interpreted as indicating that the cerebral circulation remains un changed even if the cardiac function is accelerated, as long as autoregulation is maintained. However, cerebral blood vessels in vasospasm are spastic vessels lacking elasticity while the cerebral circula tion is strongly influenced by the systemic circula tion. So it would be reasonable to think that the acceleration of the cardiac function might directly lead to an improvement in cerebral circulation. Dopamine, one of the cardiotonic drugs, is liable to induce dehydration due to its potent diuretic effect by increasing renal blood flow. Dopamine and iso proterenol have positive inotropic effects but pro duce a decrease in stroke volume because they strong ly promote increased heart rate, possibly leading to a decrease in the cerebral circulatory blood volume for every pulse beat. This decrease of CBF associated with one pulse beat may contribute to a decrease in the inside pressure of the spastic vessels, thus dam aging cerebral circulation, even if there is an ap parent increase in BP. In short, it is important to keep the systemic circulation in a hyperdynamic state in such a way that the stroke volume is not lowered but rather increased. In this context, DOB which has a strong positive inotropic effect but low heart rate promotion and diuretic effects is probably the best catecholamine currently available for the treatment of cerebral vasospasm.9)
Essentially DOB is used in the form of continuous microdose administration on the basis of the number of y calculated per body weight and time (min), but it should not be administered on a BP basis. In setting the dose, we referred to the cardiac index and set the target at 4.5-5.5 1/min/m2 as proposed by Finn et al.4) In view of the report pointing out the develop ment of tachyphylaxis,18) caution should be exercised in chosing the dosage. Insertion of a S-G catheter is required for the precise evaluation of systemic cir culaton, but catheter insertion is not always possible in patients. Therefore, less invasive approaches in cluding the dye dilution method must be considered.
III.
Patient control Prevention of dehydration:
As mentioned above, it is highly probable that dehydration may decrease cerebral circulation during the period of cerebral vasospasm.
Patients with ruptured aneurysms are liable to become dehydrated due to the decrease in water consumption caused by disturbance of con sciousness, fever, vomiting, and use of dehydration agents. The central venous pressure (CVP), which is measured to evaluate the circulatory blood volume, only reflects the pressure of the right heart, and this pressure is not correlated with the PWP once it ex ceeds 8 mmHg.l4> In elderly patients and patients with cardiovascular disorders, furthermore, it is dan gerous to accept the value as it is." Dehydration may also be caused by fever resulting from catheter bacteremia, and thus caution should be exercised in the patients with CVP catheter. In patients with intracerebral hematoma, dehydration agents such as mannitol must additionally be used but excessive dehydration should be avoided. We make it a rule to minimize the use of dehydration agents, believing that the free use of dehydration agents is contra dictory to DOB therapy. If the patient develops tachycardia of over 130/min with the DOB adminis tration, we usually supplement the fluids suffi ciently because we believe that the heart is simply working ineffectively if dehydration is present. Earlier we resorted to blood products including albumin as volume expanders, but we are now using hydroxyethyl starch instead because blood products are too expensive to be used freely. Hydroxyethyl starch is an inexpensive and completely effective agent for preventing dehydration and causes no com plications, but even hydroxyethyl starch is not re quired in patients who do not present the state of dehydration on usual fluid transfusion. Measurement of CBF: We make it a rule to conduct serial measurements of CBF by the 133Xe intravenous injection in patients with cerebral vasospasm. Although the method does not provide a three-dimensional analysis, it is a useful tool to evaluate the cerebral circulation because it is highly reproducible and permits repeated measurements. Immediately after the operation, the brain tissue usually becomes hyperemic and presents high CBF values. Therefore, by using the CBF level at around day 4 after the onset as a reference, we usually ad minister DOB promptly if CBF falls below that level. Furthermore, this kind of repeated quantitative evaluation of CBF is also useful for evaluation of the therapeutic effect of DOB administration.
It is impor tant in the treatment of vasospasm that the physician should not miss the optimum time for initiation of treatment. Once a patient develops decrease in food intake, restlessness or akinesia, talkativeness or silence and an uncooperative attitude aside from the well known neurological symptoms such as paresis and aphasia, the physician should start the treatment at once, assuming that they represent ischernic symp toms due to vasospasm. More recently, the measure ment of the flow velocity based on the transcranial Doppler technique has been practiced. This is a very useful method to identify spastic blood vessels before the development of symptomatic vasospasm.
Management of BP and respiration: As reported above, we could obtain satisfactory therapeutic results in patients with cerebral vasospasm without raising the BP. In the treatment of our hypertensive patients, therefore, we make it a rule to reduce the BP soon after the operation, employing the systolic BP of 150 mmHg as a reference. Oral administration of peripheral vasodilators such as Cam antagonists and angiotensin I converting enzyme inhibitors con stitutes our first choice of treatment, but we often find it necessary to administer /3-blockers in patients with essential hypertension showing marked left ven tricular hypertrophy.
Use of DOB in the treatment of cerebral vasospasm during the administration of l-blockers may appear to be contradictory, but the therapeutic effects may be more easily evaluated by controlling the systemic circulation hyperdynamical ly through the graded DOB administration after the BP is reduced to within the normal range before the patient enters the period of cerebral vasospasm.
The series of patients reported here included one patient in whom cerebral infarction occurred due to cerebral vasospasm.
This patient has a history of thoracoplasty due to pulmonary tuberculosis and was found to have a complication of severe broncho pneumonia on the remaining lung. The patient required forced and controlled ventilation which resulted in a significant increase of airway pressure, leading to a decrease in venous return and reduction of cardiac output, which was probably responsible for the development of cerebral infarction. Con trol ventilation causing a significant increase in airway pressure as well as excessive positive end expiratory pressure may decrease the venous return, leading to reduction of the cardiac function and even damage to the cerebral circulation in the end.') In the treatment of patients with bronchopneumo nia special attention should be paid to this point. In addition, operations conducted under general anes thesia with forced ventilation, such as shunt opera tions, should not be carried out in the period of cerebral vasospasm.
